Authors:
BARLOZZARI T
NELSON CM
SMITH PA
CONLON D
AHMED A
CHOQUETTE D
HAUPT A
Citation: T. Barlozzari et al., NOVEL DERIVATIVES OF DOLASTATIN-15 WITH IMPROVED PHARMACOLOGICAL PROFILE AS COMPARED TO LU103793 (CEMADOTIN-HCL), Annals of oncology, 9, 1998, pp. 346-346
Authors:
BRANA MF
CASTELLANO JM
PERRON D
MAHER C
CONLON D
BOUSQUET PF
GEORGE J
QIAN XD
ROBINSON SP
Citation: Mf. Brana et al., CHROMOPHORE-MODIFIED BIS-NAPHTHALIMIDES - SYNTHESIS AND ANTITUMOR-ACTIVITY OF BIS-DIBENZ[DE,H]ISOQUINOLINE-1,3-DIONES, Journal of medicinal chemistry, 40(4), 1997, pp. 449-454
Authors:
BRANA MF
DEVEGA MJP
PERRON D
CONLON D
BOUSQUET PF
ROBINSON SP
Citation: Mf. Brana et al., BENZIMIDAZO[1,2-C]QUINAZOLINE DIMERS AS POTENTIAL ANTITUMOR AGENTS, Journal of heterocyclic chemistry, 34(3), 1997, pp. 807-812
Authors:
BRANA MF
CASTELLANO JM
MORAN M
DEVEGA MJP
PERRON D
CONLON D
BOUSQUET PF
ROMERDAHL CA
ROBINSON SP
Citation: Mf. Brana et al., BIS-NAPHTHALIMIDES .3. SYNTHESIS AND ANTITUMOR-ACTIVITY OF N,N'-BIS[2-(1,8-NAPHTHALIMIDO)-ETHYL] ALKANEDIAMINES, Anti-cancer drug design, 11(4), 1996, pp. 297-309
Authors:
CONLON D
JOHNSTON A
OMALLEY K
TURNER P
KILFEATHER S
Citation: D. Conlon et al., EFFECT OF AGING AND PROPRANOLOL ADMINISTRATION ON MYOCARDIAL BETA-ADRENOCEPTOR RECEPTOR FUNCTION IN MATURE RATS, European journal of pharmacology. Molecular pharmacology section, 289(2), 1995, pp. 283-290
Authors:
BOUSQUET PF
BRANA MF
CONLON D
FITZGERALD KM
PERRON D
COCCHIARO C
MILLER R
MORAN M
GEORGE J
QIAN XD
KEILHAUER G
ROMERDAHL CA
Citation: Pf. Bousquet et al., PRECLINICAL EVALUATION OF LU-79553 - A NOVEL BIS-NAPHTHALIMIDE WITH POTENT ANTITUMOR-ACTIVITY, Cancer research, 55(5), 1995, pp. 1176-1180
Authors:
BARONE LM
ARONOW MA
TASSINARI MS
CONLON D
CANALIS E
STEIN GS
LIAN JB
Citation: Lm. Barone et al., DIFFERENTIAL-EFFECTS OF WARFARIN ON MESSENGER-RNA LEVELS OF DEVELOPMENTALLY-REGULATED VITAMIN-K-DEPENDENT PROTEINS, OSTEOCALCIN, AND MATRIXCLA PROTEIN IN-VITRO, Journal of cellular physiology, 160(2), 1994, pp. 255-264